In Future virology
Novel COVID-19 is a public health emergency that poses a serious threat to people worldwide. Given the virus spreading so quickly, novel antiviral medications are desperately needed. Repurposing existing drugs is the first strategy. Anti-parasitic drugs were among the first to be considered as a potential treatment option for this disease. Even though many papers have discussed the efficacy of various anti-parasitic drugs in treating COVID-19 separately, so far, no single study comprehensively discussed these drugs. This study reviews some anti-parasitic recommended drugs to treat COVID-19, in terms of function and in vitro as well as clinical results. Finally, we briefly review the advanced techniques, such as artificial intelligence, that have been used to find effective drugs for the treatment of COVID-19.
Panahi Yasin, Dadkhah Masoomeh, Talei Sahand, Gharari Zahra, Asghariazar Vahid, Abdolmaleki Arash, Matin Somayeh, Molaei Soheila
COVID-19, SARS-CoV-2, anti-parasitic drugs, artificial intelligence, drug repositioning, epidemic, pandemic